Preparation and characterization of magnetically responsive bacterial polyester based nanospheres for cancer therapy

Journal of Biomedical Nanotechnology

Volumn 8, Issue 5, 2012, Pages 800-808

  Erdal, Ebru ^a   Kavaz, Doǧa ^a   Şam, Mesut ^b   Demirbilek, Murat ^a   Demirbilek, Melike Erol ^b   Saǧlam, Necdet ^a,b   Denkbaş, Emir Baki ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b AKSARAY UNIVERSITY   (Turkey)

Author keywords

Cancer therapy; Concanavalin A; Etaposide; Magnetically responsive nanospheres; Polyhydroxybutyrate

Indexed keywords

AFM; ALCALIGENES EUTROPHUS; ATOMIC FORCE MICROSCOPE (AFM); BACTERIAL POLYESTERS; CANCER CELLS; CANCER THERAPY; CELL LINES; CERVICAL CANCER CELLS; CONCANAVALIN-A; ENGINEERED TISSUES; ETAPOSIDE; ETOPOSIDE; FOURIER TRANSFORM INFRARED SPECTROMETRY; HELA CELL LINE; IN-VITRO; IN-VIVO; IRON OXIDE PARTICLES; MAGNETIC CARRIERS; MAGNETIC NANOPARTICLES; MOUSE-FIBROBLASTS; POLY-HYDROXYALKANOATE; POLYHYDROXYALKANOATES; POLYHYDROXYBUTYRATE; THERMOPLASTIC POLYESTERS; VIBRATING SAMPLE MAGNETOMETER;

ATOMIC FORCE MICROSCOPY; BIOMECHANICS; CELL CULTURE; DRUG DELIVERY; EMULSIFICATION; ESTERS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; IRON OXIDES; MECHANICAL PROPERTIES; NANOMAGNETICS; NANOPARTICLES; NANOSPHERES; ONCOLOGY; SCANNING ELECTRON MICROSCOPY; TISSUE;

SCAFFOLDS (BIOLOGY);

CONCANAVALIN A; ETOPOSIDE; IRON OXIDE; NANOCARRIER; POLY(3 HYDROXYBUTYRIC ACID);

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CHEMOTHERAPY; CELL STRAIN L 929; CONTROLLED STUDY; CUPRIAVIDUS NECATOR; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTRON SPIN RESONANCE; HELA CELL; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MAGNETOMETRY; MOUSE; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; VIBRATING SAMPLE MAGNETOMETRY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; CONCANAVALIN A; CUPRIAVIDUS NECATOR; ETOPOSIDE; HELA CELLS; HUMANS; MAGNETITE NANOPARTICLES; MATERIALS TESTING; NANOCAPSULES; NANOSPHERES; POLYHYDROXYALKANOATES;

EID: 84865115656     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2012.1431     Document Type: Article

References (38)

1. G. A. Silva, Introduction to nanotechnology and its applications to medicine. Surgical Neurology 61, 216 (2004).
2. E. B. DenkbaŞ and A. Vaseashta, Nanotechnology in medicine and health sciences. NANO: Brief Reports and Reviews 3, 263 (2008).
3. N. R. Bachur, Encyclopedia of Cancer, 2nd edn., edited by J. R. Bertino, Academic Press, (2002) Vol. 1, pp. 57-61.
4. M. R. Alison (ed.), The Cancer Handbook, Nature Publishing Group, London (2003).
5. R. Catane, N. I. Cherny, M. Kloke, S. Tanneberger, and D. Schrijvers (ed.), Handbook of Advanced Cancer Care, Taylor & Francis, Oxford (2006).
6. J Gabriel (ed.), The Biology of Cancer, John Wiley & Sons, New York (2007).
7. H. D. Han, C. K. Song, Y. S. Park, K. H. Nohb, J. H. Kimb, T. Hwang, T. W. Kimb, and B. C. Shin, A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. Int. J. Pharm. 350, 27 (2008).
8. T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, J. X. Xiao, and T. Kissel, Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake?. Eur. J. Pharm. Biopharm 50, 147 (2000).
9. C. P. Reis, R. J. Neufeld, A. J. Ribeiro, and F. Veiga, Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2, 8 (2006).
10. Z. Liu, Y. Jiao, Y. Wang, C. Zhao, and Z. Zhang, Polysaccharides-based nanoparticles as drug delivery systems. Advanced Drug Delivery Reviews 60, 15, 1650 (2008).
11. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm 55, R1 (1989).
12. S. Galindo-Rodriguez, E. Allemann, H. Fessi, and E. Doelker, Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm. Res. 21, 1428 (2004).
13. A. Budhian, S. J. Siegel, and K. I. Winey, Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int. J. Pharm. 336, 367 (2007).
14. V. G. Babak, F. Baros, O. Boulanouar, F. Boury, M. Fromm, N. R. Kildeeva, N. Ubrich, and P. Maincent, Impact of bulk and surface properties of some biocompatible hydrophobic polymers on the stability of methylene chloride-in-water mini-emulsions used to prepare nanoparticles by emulsification-solvent evaporation. Colloids Surf. B. 59, 194 (2007).
15. F. S. Poletto, A. L. Fiel, B. Donida, I. Maria Re', S. S. Guterres, and A. R. Pohlmann, Controlling the size of poly(hydroxybutyrate-cohydroxyvalerate) nanoparticles prepared by emulsification-diffusion technique using ethanol as surface agent. Colloids and Surfaces A: Physicochem. Eng. Aspects 324, 105 (2008).
16. S. M. Bentzen, Theragnostic imaging for radiation oncology: Dose-painting by Numbers. Lancet Onco l6, 112 (2005).
17. T. Neuberger, B. Schopf, H. Hofmann, M. Hofmann, and B. Rechenberg, Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 293, 483 (2005).
18. S. Y. Lee, Bacterial Polyhydroxyalkanoates. Biotechnol. Bioeng. 49, 1 (1996).
19. K. H. Law, Y. C. Cheng, Y. C. Leung, W. H. Lo, H. Chua, and H. F. Yu, Construction of recombinant bacillus subtilis strains for polyhydroxyalkanoates synthesis. Biochem. Eng. J. 16, 203 (2003).
20. C. Bayram, E. Kiliçay, H. B. Çakmak, B. Hazer, I. Noda, E. B. DenkbaŞ, Preparation and characterization of triamcinolone acetonide loaded poly(3-hydroxybutyrate-co-3- hydroxyhexanoate) (PHBHx) microspheres. J. Bioact. Compat. Polym. 23, 334 (2008).
21. G. Chen and Q. Wu, The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials 26, 6565 (2005).
22. X. Qu, Q. Wu, K. Zhang, and G. Q. Chen. In vivo studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) based polymers: Biodegradation and tissue reactions. Biomaterials 27, 3540 (2006).
23. G. Tiegs, J. Hentschel, and A. Wendel, T cell-dependent experimental liver injury in mice inducible by concanavalin. A. J. Clin. Invest. 90, 196 (1992).
24. D. F. Senear and D. C. Teller, Effects of saccharide and salt binding on dimer-tetramer equilibrium of concanavalin A. Biochemistry 26, 3083 (1981).
25. D. Kavaz, S. Odabaş, E. Güven, M. Demirbilek, and E. B. Denkbaş, Bleomycin loaded magnetic Chitosan nanoparticles as multifunctional nanocarriers. J. Bioact. Compat. Polym. 25, 305 (2010).
26. J. Weyermanna, D. Lochmanna, and A. Zimmer, A practical note on the use of cytotoxicity assays. Int. J. Pharm. 288, 369 (2005).
27. M. Yamaura, R. L.Camilo, L. C. Sampao, M. A. Macedo, M. Nakamura, and H. E. Toma, Preparation and characterization of (3-Aminopropyl)Triethoxysilane- coated magnetite nanoparticles. J. Magn. Magn. Mater. 279, 210 (2004).
28. S. Rello-Varona, A. Gamez, V. Moreno, J. C. Stockert, J. Cristobal, M. Pacheco, M. Canete, A. Juarranz, and A. Villanueva, Metaphase arrest and cell death induced by etoposide on HeLa cells. Int. J. Biochem. Cell Biol. 38, 2183 (2006).
29. F. E. Smith, Tetrazolium Salt. Science 113, 751 (1951).
30. L. L. Rodriguez, J. L. Vidal, J. B. Mendez, and A. L. Alvarez, Incorporation of PVMMA to PLGA MS enhances lectin grafting and their in vitro activity in macrophages. Int. J. Pharm. 402, 165 (2010).
31. M. Moros, B. Pelaz, P. L. Larrubia, M. L. G. Martin, V. Grazua, and J. M. de la Fuente, Engineering biofunctional magnetic nanoparticles for biotechnological applications. The Royal Society of Chemistry 2, 1746 (2010).
32. V. Kekkonen, N. Lafreniere, M. Ebara, A. Saito, Y. Sawa, and R. Narain, Synthesis and characterization of biocompatible magnetic glyconanoparticles. J. Magn. Magn. Mater. 321, 1393 (2009).
33. S. I. Van Kasteren, S. J. Campbell, S. Serres, D. C. Anthony, N. R. Sibson, and B. G. Davis, Glyconanoparticles allow presymptomatic in vivo imaging of brain disease. Proc. Natl. Acad. Sci. U. S. A. 106, 18 (2009).
34. C. Gilles, M. Polette, J. Piette, C. Munaut, E. W. Thompson, P. Birembaut, and J. M. Foida, High level of MT-MMP expression is associated With invasiveness of cervical cancer cells. Znt. J. Cancer 65, 209 (1996).
35. T. Zhang, J. Chen, Y. Zhang, Q. Shen, and W. Pan, Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. European Journal of Pharmaceutical Sciences 43, 174 (2011).
36. B. C. Tang, J. Fu, D. N. Watkins, and J. Hanes, Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo. Biomaterials 31, 339 (2010).
37. A. Lamprecht and J. Benoit, Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J. Controlled Release 112, 208 (2006).
38. G. Gaucher, M. Poreba, F. O. Ravenelle, and J. C. Leroux, Poly (N-Vinyl-Pyrrolidone)-Block-Poly(D,L-Lactide) as Polymeric Emulsifier for the preparation of biodegradable nanoparticles. Journal of Pharmaceutical Sciencesvol. 96, 7 (2007).